National Taiwan University Hospital_main
Taipei 100
0 studies enrolling now · 8 studies all time
What they study most
Cardiovascular Risk, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Early Alzheimer´s Disease, Haemophilia A, Haemophilia A With Inhibitors, Inflammation, Non-alcoholic Steatohepatitis, Obesity, Peripheral Arterial Disease, Type 2 Diabetes
Studies at this site
- A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A — Recruiting now
- Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) — Running, not enrolling
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
- A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight — Running, not enrolling
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
- A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes — Completed
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
- Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) — Completed